The Clicks growth strategy is moving the retailer beyond its pharmacy roots, with CEO Bertina Engelbrecht targeting GLP-1 medicines, specialist healthcare and medical consumables. Clicks has raised its pharmacy market share to 24.7% and operates 835 pharmacies and 225 clinics. GLP-1 medicines the biggest near-term opportunity Engelbrecht sees GLP-1 medicines as the biggest short-term opportunity. These drugs treat diabetes and…
Clicks Growth Strategy Targets GLP-1 Medicines, Oncology
